Zoetis | ZTS - Cash And Equivalent

Stock Price
126.73
Daily Change
0.03 0.02%
Monthly
-2.03%
Yearly
-27.22%
Q1 Forecast
120.98

Zoetis reported $2.08B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
AbbVie USD 5.63B 838M Sep/2025
Align Technology USD 1B 103.43M Sep/2025
Bayer EUR 5.9B 1.34B Sep/2025
Bristol-Myers Squibb USD 15.73B 3.13B Sep/2025
Charles River Laboratories USD 207.1M 24.27M Sep/2025
Dentsply International USD 363M 4M Sep/2025
Eli Lilly USD 9.79B 6.42B Sep/2025
Henry Schein USD 136M 9M Sep/2025
Idexx Laboratories USD 208.17M 43.57M Sep/2025
Illumina USD 1.05B 116M Sep/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
J&J USD 18.23B 10.35B Sep/2025
Laboratory Of America USD 598.1M 49.2M Sep/2025
Merck USD 18.17B 10.16B Sep/2025
Neogen USD 145.34M 6.46M Sep/2025
Pacira USD 147.59M 152.89M Sep/2025
Perrigo USD 432.1M 22.1M Sep/2025
Pfizer USD 1.34B 295M Sep/2025
Quest Diagnostics USD 432M 113M Sep/2025
Sanofi EUR 7.66B 1.25B Dec/2025
Sanofi EUR 7.66B 1.25B Dec/2025
Zoetis USD 2.08B 649M Sep/2025